The classic website will no longer be available as of June 25, 2024. Please use the modernized ClinicalTrials.gov.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

The Effect of Pelvic Floor Physiotherapy on Vaginal Elasticity

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04114019
Recruitment Status : Withdrawn (The study device became unavailable for use.)
First Posted : October 3, 2019
Last Update Posted : July 27, 2020
Sponsor:
Information provided by (Responsible Party):
ROY LAUTERBACH MD, Rambam Health Care Campus

Brief Summary:
Women suffering from stress urinary incontinence are offered pelvic floor physiotherapy as an optional treatment. Strengthening of the pelvic floor is measured to date by manual examination and lacks precise evaluation. The vaginal tactile imager assists in evaluation of the changes in the pelvic floor after physiotherapy.

Condition or disease Intervention/treatment
Stress Urinary Incontinence Diagnostic Test: Vaginal tactile imager

Detailed Description:
Women with stress urinary incontinence will undergo 6-10 pelvic floor strengthening physiotherapy sessions. The participants will undergo a short examination of vaginal elasticity using a vaginal tactile imager prior to beginning physiotherapy and additional examinations after 6 treatments, 10 treatments and 3 and 6 months post-treatment cessation.

Layout table for study information
Study Type : Observational
Actual Enrollment : 0 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: The Effect of Pelvic Floor Physiotherapy on Vaginal Elasticity as Measured by a Vaginal Tactile Imager
Estimated Study Start Date : July 1, 2020
Estimated Primary Completion Date : December 30, 2020
Estimated Study Completion Date : April 1, 2021

Resource links provided by the National Library of Medicine


Group/Cohort Intervention/treatment
Stress urinary incontinence
Women suffering from stress urinary incontinence
Diagnostic Test: Vaginal tactile imager
Vaginal elasticity evaluation using a vaginal tactile imager




Primary Outcome Measures :
  1. Vaginal Elasticity [ Time Frame: From the treatment cessation up to 6 months post-treatment ]
    Changes in vaginal elasticity post physiotherapy


Secondary Outcome Measures :
  1. Stress urinary incontinence [ Time Frame: From the treatment cessation up to 6 months post-treatment ]
    Improvement in the urogenital distress inventory questionnaire score (range 0-15)



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 70 Years   (Adult, Older Adult)
Sexes Eligible for Study:   Female
Gender Based Eligibility:   Yes
Gender Eligibility Description:   Female
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Women between 18-70 years of age, suffering from stress urinary incontinence, referred to pelvic floor physiotherapy.
Criteria

Inclusion Criteria:

  • women suffering from stress urinary incontinence.

Exclusion Criteria:

  • women suffering from urge urinary incontinence.
  • women suffering of mixed urinary incontinence.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04114019


Sponsors and Collaborators
Rambam Health Care Campus
Investigators
Layout table for investigator information
Principal Investigator: Roy Lauterbach, MD Rambam Health Care Campus
Layout table for additonal information
Responsible Party: ROY LAUTERBACH MD, Principal Investigator, Rambam Health Care Campus
ClinicalTrials.gov Identifier: NCT04114019    
Other Study ID Numbers: 0327-19-RMB
First Posted: October 3, 2019    Key Record Dates
Last Update Posted: July 27, 2020
Last Verified: July 2020
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Additional relevant MeSH terms:
Layout table for MeSH terms
Urinary Incontinence
Urinary Incontinence, Stress
Urination Disorders
Urologic Diseases
Female Urogenital Diseases
Female Urogenital Diseases and Pregnancy Complications
Urogenital Diseases
Male Urogenital Diseases
Lower Urinary Tract Symptoms
Urological Manifestations